Combined therapy of amifostine and gemcitabine in high-risk myelodysplastic syndromes

被引：0
|
作者：
Sezer, O [1 ]
Dingeldein, G [1 ]
Mergenthaler, HG [1 ]
Possinger, K [1 ]
机构：
[1] HUMBOLDT UNIV BERLIN,KLINIKUM CHAR,MED KLIN 2,BERLIN,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：419 / 419
页数：1
相关论文
共 50 条
  • [1] Combined therapy with amifostine plus erythropoietin for the treatment of myelodysplastic syndromes
    Grossi, A
    Musto, P
    Santini, V
    Balestri, F
    Fabbri, A
    Falcone, A
    Sanpaolo, G
    [J]. HAEMATOLOGICA, 2002, 87 (03) : 322 - 323
  • [2] Treatment of high-risk myelodysplastic syndromes
    Fenaux, Pierre
    [J]. HEMATOLOGIE, 2006, 12 : 12 - 13
  • [3] Treating high-risk myelodysplastic syndromes
    Ades, Lionel
    [J]. BULLETIN DU CANCER, 2023, 110 (11) : 1162 - 1167
  • [4] Management of high-risk myelodysplastic syndromes
    Pisani, FD
    Rainaldi, A
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 40 (03) : 215 - 228
  • [5] High-risk myelodysplastic syndromes in hypomethylants failure
    Gardin, Claude
    [J]. HEMATOLOGIE, 2010, 16 : 24 - 28
  • [6] Treatment of patients with high-risk myelodysplastic syndromes
    Gattermann, Norbert
    Kuendgen, Andrea
    Germing, Ulrich
    [J]. CANCER TREATMENT REVIEWS, 2007, 33 : S64 - S68
  • [7] Histopathology in the diagnosis of high-risk myelodysplastic syndromes
    Kayano, Hidekazu
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2018, 58 (02) : 51 - 60
  • [8] Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities
    Hiddemann, W
    Jahns-Streubel, G
    Verbeek, W
    Wörmann, B
    Haase, D
    Schoch, C
    [J]. LEUKEMIA RESEARCH, 1998, 22 : S23 - S26
  • [9] Azacitidine therapy in high-risk myelodysplastic syndromes (MDS): A single centre experience
    Improta, S.
    Gagliardi, A.
    Villa, M. R.
    Della Cioppa, P.
    Esposito, M.
    Izzo, G. Nitrato
    Mastrullo, L.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S152 - S152
  • [10] Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes
    Invernizzi, R
    Pecci, A
    Rossi, G
    Pelizzari, AM
    Giusto, M
    Tinelli, C
    Ascari, E
    [J]. HAEMATOLOGICA, 1997, 82 (06) : 660 - 663
12345